Mg2+ -dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2).
暂无分享,去创建一个
[1] Adrian W. R. Serohijos,et al. Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function , 2008, Proceedings of the National Academy of Sciences.
[2] Andrei Aleksandrov,et al. Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.
[3] Angus C Nairn,et al. In vivo phosphorylation of CFTR promotes formation of a nucleotide‐binding domain heterodimer , 2006, The EMBO journal.
[4] Z. Sauna,et al. Exploiting Reaction Intermediates of the ATPase Reaction to Elucidate the Mechanism of Transport by P-glycoprotein (ABCB1)* , 2006, Journal of Biological Chemistry.
[5] C. Fan,et al. Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator , 2006, Cell.
[6] R. Tampé,et al. Kinetics of the ATP Hydrolysis Cycle of the Nucleotide-binding Domain of Mdl1 Studied by a Novel Site-specific Labeling Technique* , 2006, Journal of Biological Chemistry.
[7] A. E. Senior,et al. The Occluded Nucleotide Conformation of P-Glycoprotein , 2005, Journal of bioenergetics and biomembranes.
[8] I. Braakman,et al. Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.
[9] A. E. Senior,et al. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway. , 2005, Biochemistry.
[10] Lutz Schmitt,et al. H662 is the linchpin of ATP hydrolysis in the nucleotide‐binding domain of the ABC transporter HlyB , 2005, The EMBO journal.
[11] A. E. Senior,et al. Combined Mutation of Catalytic Glutamate Residues in the Two Nucleotide Binding Domains of P-glycoprotein Generates a Conformation That Binds ATP and ADP Tightly* , 2004, Journal of Biological Chemistry.
[12] J. M. Sauder,et al. Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator , 2004, The EMBO journal.
[13] A. Nairn,et al. Prolonged Nonhydrolytic Interaction of Nucleotide with CFTR's NH2-terminal Nucleotide Binding Domain and its Role in Channel Gating , 2003, The Journal of general physiology.
[14] A. Nairn,et al. Distinct Mg2+-dependent Steps Rate Limit Opening and Closing of a Single CFTR Cl− Channel , 2002, The Journal of general physiology.
[15] J. Riordan,et al. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover* , 2002, The Journal of Biological Chemistry.
[16] A. Powe,et al. Mutation of Walker‐A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide‐binding domains , 2002, The Journal of physiology.
[17] C. Higgins,et al. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. , 2001, Biochemistry.
[18] J. Hunt,et al. Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. , 2001, Structure.
[19] J. Riordan,et al. Differential Interactions of Nucleotides at the Two Nucleotide Binding Domains of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2001, The Journal of Biological Chemistry.
[20] A. M. George,et al. Symmetry and structure in P-glycoprotein and ABC transporters what goes around comes around. , 2000, European journal of biochemistry.
[21] C. Bear,et al. Purified Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Does Not Function as an ATP Channel (*) , 1996, The Journal of Biological Chemistry.
[22] A. E. Senior,et al. The catalytic cycle of P‐glycoprotein , 1995, FEBS letters.
[23] A. E. Senior,et al. Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. , 1993, The Journal of biological chemistry.
[24] Z. Sauna,et al. The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein , 2001, Journal of bioenergetics and biomembranes.